Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$1.60
-$0.07-4.19%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -54.12% | 109.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -42.03% | 32.50% | |||
| Operating Income | 42.03% | -32.50% | |||
| Income Before Tax | 36.67% | -21.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 36.67% | -21.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.67% | -21.41% | |||
| EBIT | 42.03% | -32.50% | |||
| EBITDA | 42.05% | -32.55% | |||
| EPS Basic | 68.07% | 56.66% | |||
| Normalized Basic EPS | 68.07% | 56.66% | |||
| EPS Diluted | 68.07% | 56.66% | |||
| Normalized Diluted EPS | 68.07% | 56.66% | |||
| Average Basic Shares Outstanding | 98.36% | 180.12% | |||
| Average Diluted Shares Outstanding | 98.36% | 180.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||